MARKET

CLVLF

CLVLF

Clinuvel Pharma
OTCPK
6.10
NaN%
Closed 09:30 07/24 EDT
OPEN
--
PREV CLOSE
6.10
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
8.34
52 WEEK LOW
6.10
MARKET CAP
307.61M
P/E (TTM)
14.20
1D
5D
1M
3M
1Y
5Y
1D
Clinuvel Pharmaceuticals Reports Lapse of Performance Rights
TipRanks · 8h ago
Clinuvel shifts headquarters to U.S. in strategic overhaul
TipRanks · 4d ago
CLINUVEL implements strategic reorganisation to refocus on U.S. markets
Barchart · 4d ago
Clinuvel Starts Trading Level II ADS on Nasdaq Under CUVL
TipRanks · 5d ago
CLINUVEL upgrades U.S. listing to Nasdaq under ticker 'CUVL'
Seeking Alpha · 07/20 07:06
SCENESSE® approved for EPP in Canada
Barchart · 07/13 00:10
Clinuvel wins Health Canada approval for rare‑disease drug SCENESSE
TipRanks · 07/12 23:18
Clinuvel Extends CEO’s Term to 2029 as Board Backs Ambitious Expansion Plan
TipRanks · 07/02 01:48
More
About CLVLF
Clinuvel Pharmaceuticals Limited is a specialty pharmaceutical company. It is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the United States of America, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). It has operations in Europe, Singapore, and the United States of America. It develops and manufactures NEURACTHEL (adrenocorticotropic hormone) in different formulations, to target neurological, endocrinological, and degenerative disorders. Its pharmaceutical product, PRENUMBRA, has been developed, and its use is to be expanded in the clinic from stroke to Parkinson's.

Webull offers Clinuvel Pharmaceuticals Ltd stock information, including OTCPK: CLVLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLVLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLVLF stock methods without spending real money on the virtual paper trading platform.